The U.S. Food and Drug Administration (FDA) may not renew the Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine for children under the age of five, the company said.
The possible move would pull the only available coronavirus vaccine for young children from the market.
"We are currently in discussions with the agency on potential paths forward and have requested that the EUA for this age group remain in place for the 2025-2026 season," a spokesperson for Pfizer said in a statement to Fox News Digital.
"It is important to note that these deliberations are not related to the safety and efficacy of the vaccine which continues to demonstrate a favorable profile," it said.
Children aged 6 months to 4 years "[w]ho are moderately or severely immunocompromised" may take a Moderna shot, according to the Centers for Disease Control and Prevention's (CDC) child immunization schedule.
Otherwise, different recommendations are made for the 5-11 and 12-17-year age ranges.
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| PFE | PFIZER INC. | 24.95 | +0.32 | +1.30% |
"The COVID-19 pandemic ended with the expiration of the federal public health emergency in May 2023," an HHS spokesperson said in a statement to Fox News Digital, adding that the department does "[n]ot comment on potential, future regulatory changes."
"Unless officially announced by HHS, discussion about future agency action should be regarded as pure speculation," it said.
Back in May, Health and Human Services (HHS) Director Robert F. Kennedy Jr. sent out a post on X that read, "[T]he COVID vaccine for healthy children and healthy pregnant women has been removed from @CDCgov recommended immunization schedule."
"[W]e are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Kennedy said in June. "The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies."
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.